US Startup Funding Insights: AI Leads $1.5B Week, California Dominates Once Again
- June 19, 2025
- Posted by: spiceroute
- Category: U.S. Funding & Investment Trends

This week, 87 US startups raised a total of $1.509 billion, signaling robust investor conviction across mid-stage growth companies and emerging innovators. While Artificial Intelligence (AI) retained its dominance, the funding landscape was notably diverse — spanning sectors from biotechnology to industrial engineering. The capital distribution leaned toward Series B and A rounds, reflecting a maturation of venture-backed companies and a clear emphasis on execution and scalability. California continues to dominate, but deals in Pennsylvania, Florida, and Texas hint at a decentralizing innovation economy.
Top Industries of the Week
- Artificial Intelligence (AI) – $344M
AI attracted over 22 deals, the highest of any sector, reaffirming its cross-functional utility and investor demand. The $344M raised reveals a balanced mix of early and mid-stage bets — from Guardz’s $56M (FL) in cybersecurity AI to Ellipsis Health’s $45M (CA) in AI-powered mental health.
Investors are backing AI startups that offer real-world utility and monetizable applications. The breadth of deal stages signals that AI is now less speculative and more operational, bridging early research with execution at scale.
- Information Technology – $182M
High-value bets in IT were driven by performance software and developer tooling startups like Nominal ($75M, TX) and Abacum ($60M, NY).
There’s a pivot from infrastructure-heavy IT solutions to tools that enhance operational intelligence, team efficiency, and financial forecasting. These companies are now seen as core enablers of other startups, not just service providers — explaining why they’re attractive at Series A and B stages.
- Industrial Engineering – $134M
Gecko Robotics single-handedly contributed $125M with its Series D in Pennsylvania. Their platform enables predictive maintenance for critical infrastructure like power plants and factories.
A huge late-stage deal here shows that hard tech is resurging, especially where it’s tied to public infrastructure and national resilience. Institutional investors likely view Gecko not just as a SaaS play, but as a defensible platform in a trillion-dollar legacy industry.
- E-Commerce – $129M
Coco, based in California, secured $80M for last-mile delivery automation.
Though broader E-Commerce has cooled, automation at the edges of retail and delivery is still raising serious capital. Investors are selecting narrow, high-leverage pain points in an otherwise saturated sector.
- Biotechnology – $111M
Biotech saw a major lift with Mosanna Therapeutics’ $80M Series A in California.
Securing this much at Series A in biotech indicates strong clinical promise and IP defensibility. Investors continue to treat biotech as a long-horizon bet, but only when startups demonstrate validated science and a fast route to regulatory inflection points.
Funding Stage Analysis
Series B – $537M | 12 Deals
Mid-stage startups are raising larger rounds earlier, indicating strong early traction and aggressive scaling goals.
Series A – $484M | 23 Deals
High deal count shows investors are betting on post-seed momentum — confident in companies’ product-market fit and go-to-market muscle.
Series D – $275M | 3 Deals
These mega-deals (e.g., Gecko Robotics) show investors are still writing big checks to category leaders who may IPO or consolidate soon.
Pre-Seed – $6M | 5 Deals
Lower total reflects more selective seed investing, possibly emphasizing incubation-stage innovation or founder-market fit.
Seed – Not Explicitly Broken Out | 44 Deals (in overall deal count)
This is the most active stage by volume, underscoring a rich pipeline of new startups. Capital is going to founders solving real-world operational problems, with investors showing confidence in smaller, nimble teams.
The dominance of Series B and A indicates that investors are increasingly focused on execution risk, not just ideation risk. It’s no longer enough to have a vision — teams must show traction, team scalability, and customer validation to raise meaningful capital.
Outliers
Rank | Company | Funding | Stage | Sector | State |
1 | Gecko Robotics | $125M | Series D | Industrial Engineering | Pennsylvania |
2 | Canary Technologies | $80M | Series D | Software | California |
3 | Coco | $80M | Series B | E-Commerce | California |
4 | Mosanna Therapeutics | $80M | Series A | Biotechnology | California |
5 | Nominal | $75M | Series B | Information Technology | Texas |
6 | PostHog | $70M | Series D | Developer Tools | California |
7 | Abacum | $60M | Series A | Information Technology | New York |
8 | Guardz | $56M | Series B | Artificial Intelligence | Florida |
9 | Tastewise | $50M | Series B | Artificial Intelligence | New York |
10 | Ellipsis Health | $45M | Series A | Artificial Intelligence | California |
These top 10 deals collectively absorbed over $721M, or nearly 48% of weekly capital, underscoring a “winner-takes-most” dynamic. Capital continues to consolidate around high-conviction, proven teams and platforms.
Notable Deals
- Gecko Robotics ($125M) – Proving that hardware plus software in industrials is investable again.
- Mosanna Therapeutics ($80M) – Rare Series A biotech round at this size; signals de-risked science.
- PostHog ($70M) – Demonstrates sustained appetite for devtools with usage-based pricing models.
- Guardz & Tastewise ($50M+) – Enterprise AI with specific vertical applications (security and consumer insights).
Geographic Highlights
State | Total Funding | Deal Volume |
California | $604M | 29 |
New York | $331M | 17 |
Pennsylvania | $189M | 5 |
Texas | $119M | 6 |
Florida | $62M | 6 |
California retained its leadership with nearly 40% of total funding, housing top-funded startups across AI, biotech, and software. New York continued as a major capital magnet with $331M, mainly concentrated in AI and IT. Pennsylvania’s ranking was propelled by Gecko Robotics, while Texas and Florida further established themselves as viable innovation ecosystems suggesting non-coastal regions are now attracting substantial late-stage capital. Investors are expanding their geographic lens — but only for startups with category-defining value propositions.
Key Takeaways
- AI Is Moving From Hype to ROI
Rather than speculative R&D, funding is now flowing to AI applications that drive revenue or reduce cost — from fraud detection to customer intelligence.
- Series B and A Are Where It’s At
The twin engines of funding — Series B ($537M) and Series A ($484M) — indicate a strong belief in execution-stage companies, not just startups chasing PMF.
- Geographic Fragmentation Is Slow but Real
California isn’t going anywhere, but outliers like Pennsylvania and Florida are winning large checks when they have the tech and traction to back it.
- Sector Diversification Signals Maturity
Industrial, biotech, and developer tools had major wins this week, showing that capital is no longer fixated on “hot” sectors only — it’s flowing to business models that make sense.
Final Thoughts
This week’s $1.5 billion in startup capital tells a story of mature investor behavior — a shift from spray-and-pray to precision and traction. With Artificial Intelligence leading the charge and Series B/A stages absorbing most capital, startups are increasingly judged on their ability to scale and sustain. California still commands the spotlight, but rising activity in Pennsylvania, Florida, and Texas hints at a more distributed innovation economy in the making. Overall, it was a week defined by confidence, concentration, and conviction.